Researchers have cut short a study testing the drug after patients developed irregular heart rates and nearly two dozen died.
The drug had previously been described as a “game changer” by the US President.
The study sponsored by the Brazilian state of Amazonas was published in the Journal of the American Medical Association (JAMA).
Researchers treated 81 COVID-19 patients with the drug between March 23 and April 5 at a medical facility in Brazil.
More to follow…
Source: Read Full Article